Biswarup Basu

Biswarup Basu

Auto-generated profile, based on publicly available information

Biswarup Basu

Department of Neuroendocrinology CNCI Kolkata India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
CSChandrani Sarkar
Chandrani Sarkar
BBBiswarup Basu
Biswarup Basu
DCDebanjan Chakroborty
Debanjan Chakroborty
PDPartha Sarthi Dasgupta
Partha Sarthi Dasgupta
SBSujit Basu
Sujit Basu

30 April 2009 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DCDebanjan Chakroborty
Debanjan Chakroborty
CSChandrani Sarkar
Chandrani Sarkar
BBBiswarup Basu
Biswarup Basu
PDPartha Sarathi Dasgupta
Partha Sarathi Dasgupta
SBSujit Basu
Sujit Basu
Among the regulators of angiogenesis, catecholamine neurotransmitters are of recent interest because of their opposite roles in the regulation of tumor neovascularization. Norepinephrine and epinephrine by acting through specific adrenoceptors increase the synthesis of proangiogenic factors, and thereby, promote tumor growth. In contrast, dopamine acting via its specific D2 receptors inhibits tumor growth by suppressing the actions of vascular permeability factor/vascular endothelial growth factor-A on both tumor endothelial and bone marrow-derived endothelial progenitor cells. These reports identify novel endogenous regulators of tumor angiogenesis and also indicate a new and an inexpensive class of antiangiogenic drugs for the treatment of cancer. [Cancer Res 2009;69(9):3727–30]

27 June 2018 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
SSSujata Sangam
Sujata Sangam
AGApoorv Gupta
Apoorv Gupta
ASAdeeba Shakeel
Adeeba Shakeel
Rohan BhattacharyaRohan Bhattacharya
Rohan Bhattacharya
ASArun Kumar Sharma
Arun Kumar Sharma
MMMonalisa Mukherjee
Monalisa Mukherjee
The ongoing race of biomedical applications has given momentum to the development of graphene quantum dots (GQDs). GQDs are zero-dimensional fluorescent carbon-nanomaterials, with a pronounced quantum confinement effect, and abundant edge states and functional groups. Despite their potential applications, mass-scale synthesis of single crystalline graphene quantum dots (GQDs) with high quantum yields derived via a direct green synthesis approach from bio-wastes is a major challenge. Hitherto, green extract (i.e. sugarcane molasses) driven single crystalline sulphur-doped GQDs (S-GQDs) with a longer decay time, high quantum yield, and excellent biocompatibility have remained unexplored in the bioimaging arena. At the same time, this agro-industrial waste has value in terms of both products and byproducts i.e. zero waste generation resulting in reduced human footprint on the environment. For the first time, we present a facile, large-scale, one-step, economical, template- and catalyst-free synthesis of sustainable, highly crystalline S-GQDs via a hydrothermal route from second generation (2G) bio-wastes. Mechanistic insight into the formation of S-GQDs from their precursor was obtained using powder X-ray diffraction patterns (PXRD). S-GQDs directly obtained from bio-wastes without surface passivation showed the highest quantum yield (QY) ∼ 47% obtained to date. The wide and symmetric emission spectrum of these S-GQDs is instrumental for sensitive detection as labelling nanoprobes. Moreover, their non-toxic behavior, in vitro and in vivo, has a future in quick point-of-care screening and real-time bioimaging. Thus, the as-synthesized bio-waste derived S-GQDs accomplished the purpose of an advanced environmentally friendly and sustainable material which is non-toxic, viable, safe, and cheap. This unprecedented work advances the synthesis of high-quality S-GQDs from bio-waste, which provides a breakthrough in the bioimaging field.

1 December 2006 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CSChandrani Sarkar
Chandrani Sarkar
SDShamik Das
Shamik Das
DCDebanjan Chakroborty
Debanjan Chakroborty
UCUttio Roy Chowdhury
Uttio Roy Chowdhury
BBBiswarup Basu
Biswarup Basu
SBSujit Basu
Sujit Basu
The neurotransmitter dopamine (DA) is an important regulator of human T cell functions. Although it has been observed that DA, by acting through the D1/D5, D2, and D3 receptors, can activate resting T cells by stimulating the release of cytokines and the expression of surface integrins and also inhibit the proliferation of activated T cells by down-regulating nonreceptor tyrosine kinases, there is not yet a report indicating the functional significance of the D4 DA receptors present in these cells. The present work, for the first time, demonstrates that the stimulation of D4 DA receptors in human T cells induces T cell quiescence by up-regulating lung Krüppel-like factor-2 expression through the inhibition of ERK1/ERK2 phosphorylation. These results reveal a new link between the nervous system and T cell quiescence and indicate that D4 DA receptor agonists may have a therapeutic value in diseases with uncontrolled T cell proliferation.

1 January 2019 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
PKPawandeep Kaur
Pawandeep Kaur
ASArun Kumar Sharma
Arun Kumar Sharma
DNDebasish Nag
Debasish Nag
ADAmlan Das
Amlan Das
SDSatabdi Datta
Satabdi Datta
DCDiptiman Choudhury
Diptiman Choudhury

1 December 2010 in The American Journal of Pathology
Verified
Journal Article
Closed access
SGSubhalakshmi Ganguly
Subhalakshmi Ganguly
BBBiswarup Basu
Biswarup Basu
SSSaurav Shome
Saurav Shome
TJTushar Jadhav
Tushar Jadhav
SRSudipta Roy
Sudipta Roy
SBSujit Basu
Sujit Basu